{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:18:07Z","timestamp":1782793087656,"version":"3.54.5"},"reference-count":18,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":197,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematol Oncol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1002\/hon.2188","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T08:07:00Z","timestamp":1424074020000},"page":"22-27","source":"Crossref","is-referenced-by-count":26,"title":["Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma"],"prefix":"10.1002","volume":"34","author":[{"given":"Changhoon","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dok Hyun","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Sik","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Jeong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheolwon","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,16]]},"reference":[{"issue":"4","key":"10.1002\/hon.2188-BIB0001|hon2188-cit-0001","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.23608","article-title":"Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004","volume":"113","author":"Zhou","year":"2008","journal-title":"Cancer"},{"issue":"suppl 3","key":"10.1002\/hon.2188-BIB0002|hon2188-cit-0002","doi-asserted-by":"crossref","first-page":"iii83","DOI":"10.1093\/annonc\/mdu264","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Dreyling","year":"2014","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1002\/hon.2188-BIB0003|hon2188-cit-0003","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1002\/hon.2188-BIB0004|hon2188-cit-0004","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1002\/hon.2188-BIB0005|hon2188-cit-0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood-2014-03-559930","article-title":"Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study","volume":"124","author":"Abrahamsson","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1002\/hon.2188-BIB0006|hon2188-cit-0006","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"issue":"13","key":"10.1002\/hon.2188-BIB0007|hon2188-cit-0007","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","article-title":"Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the European Mantle-Cell Lymphoma Network","volume":"32","author":"Hoster","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1002\/hon.2188-BIB0008|hon2188-cit-0008","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1084\/jem.138.6.1608","article-title":"The small subunit of HL-A antigens is \u03b22-microglobulin","volume":"138","author":"Grey","year":"1973","journal-title":"J Exp Med"},{"issue":"3","key":"10.1002\/hon.2188-BIB0009|hon2188-cit-0009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","article-title":"Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor","volume":"49","author":"Yoo","year":"2014","journal-title":"Blood Res"},{"issue":"6","key":"10.1002\/hon.2188-BIB0010|hon2188-cit-0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00277-014-2015-2","article-title":"Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer\/T cell lymphoma","volume":"93","author":"Yoo","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1002\/hon.2188-BIB0011|hon2188-cit-0011","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.917640","article-title":"Prognostic impact of \u03b2 2-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma","author":"Yoo","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"28","key":"10.1002\/hon.2188-BIB0012|hon2188-cit-0012","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1200\/JCO.2005.01.1825","article-title":"High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine","volume":"23","author":"Romaguera","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1002\/hon.2188-BIB0013|hon2188-cit-0013","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2010.08228.x","article-title":"Ten-year follow-up after intense chemoimmunotherapy with rituximab-hyperCVAD alternating with rituximab-high dose methotrexate\/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma","volume":"150","author":"Romaguera","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1002\/hon.2188-BIB0014|hon2188-cit-0014","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/cncr.11838","article-title":"Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission","volume":"98","author":"Khouri","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/hon.2188-BIB0015|hon2188-cit-0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjh.12409","article-title":"Prognostic impact of monocyte count at presentation in mantle cell lymphoma","volume":"162","author":"Aprile von Hohenstaufen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1002\/hon.2188-BIB0016|hon2188-cit-0016","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"2","key":"10.1002\/hon.2188-BIB0017|hon2188-cit-0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematopathol"},{"issue":"27","key":"10.1002\/hon.2188-BIB0018|hon2188-cit-0018","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2188","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2188","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hon.2188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T06:29:21Z","timestamp":1717741761000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2188"}},"subtitle":["Beta-2 microglobulin in MCL"],"short-title":[],"issued":{"date-parts":[[2015,2,16]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/hon.2188","archive":["Portico"],"relation":{},"ISSN":["0278-0232"],"issn-type":[{"value":"0278-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,16]]}}}